Fingerprint
Dive into the research topics of 'Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy
Cell Therapy Consortium
Research output: Contribution to journal › Article › peer-review
9
Scopus
citations